These studies utilised small numbers of relatively weak genetic instruments and reported negative associations between genetically instrumented sex hormone-binding globulin (SHBG) levels and T2D risk, null effects of oestradiol (E2) and testosterone on CVD risk, and an inverse association between genetically predicted higher BMI and serum testosterone in men. This evidence concerns the gene SHBG and type 2 diabetes mellitus.